Procter & Gamble Health Share Price

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world. As of 14 Jun 2026, Procter & Gamble Health share price is ₹6,287.00. The stock opened at ₹6,210.00, compared to its previous close of ₹6,207.00. During today's trading session, Procter & Gamble Health share price moved in the range of ₹6,205.00 to ₹6,333.00, with an average price of ₹6,269.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹6,205.00 and a high of ₹6,333.00. On the performance front, Procter & Gamble Health share price has increased by 12.72% over the last six months and is up 7.66% on a year-on-year basis.

The market capitalization of Procter & Gamble Health is ₹10,414 Crs, with a P/E ratio of 31.9 and a dividend yield of 6.62%.